Annual State of Global Market Access Webinar

Home / Intelligence / Webinars / Annual State of Global Market Access Webinar

Available On Demand

Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the consequences of new therapeutic advances and policies aiming to control costs globally and the impacts for pharma manufacturers.

Register for this webinar for a deeper dive into a few trends in the white paper. Join experts from our Evidence, Value, Access & Pricing team, Maximilian Hunt, Partner, Jeff Skaar, Managing Director, and Ismail Ismailoglu, Principal, for an insightful discussion on the hot topics below.

Key Webinar Topics

  • Cell & gene therapy expansion and other new drug modalities: The evolving evidence requirements to demonstrate value for these potentially one-time/curative, high-priced therapies
  • How the greater availability of real-world evidence is shaping and impacting payer evidence expectations
  • The significant increase in market delays and withdrawals due to lower reimbursement opportunity—driven by both policy and cost cutting in U.S. and EU markets—and the implications for manufacturers
In Case You Missed It

Click here to read our white paper entitled Annual State of Global Market Access.


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

Related Intelligence


2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

May 1, 2024 | 12:00 – 12:45 PM ET / 18:00 – 18:45 CET

An additional session will be offered on May 7th at 16:00-16:45 (UTC+8:00) – Asia/Shanghai How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for […]

 Sign Up Now


Rise with the waves: Canada – A Coming (R)evolution: Transforming Pharmaceutical Market Access

Executive Summary Canada has undertaken meaningful strategies to transform patient access and ultimately improve health outcomes across the country. Two such potentially high-impact strategies include the planned transformation of the former Canadian Agency for Drugs and Technology in Health (CADTH) into the new Canadian Drug Agency (CDA) over the course of the next five years, […]

 Read More


Using Transparency in Coverage Reimbursement Insights to Inform Payer and Provider Contracting Strategy

Executive Summary “Transparency in Coverage” (TIC) data is a newer data source that has recently become available for mining unique insights in the reimbursement/economics between payers and providers. In 2020, the Federal Government TIC Rule required health insurers and group health plans, including self-funded clients, to provide cost-sharing data to consumers via machine-readable files and […]

 Read More